Dihydroergotamine mesylate is an active pharmaceutical ingredient used in the manufacturing of certain pharmaceutical products. According to state or federal government labeling requirements, it can cause developmental toxicity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 6190-39-2
Acidihydroergocristine
pharmaceutical raw material
Dihydroergocristine mesylate
pharmaceutical raw material
Dihydro-α-ergocryptine mesylate
pharmaceutical raw material
Dimepranol acedoben
pharmaceutical raw material
Adrenalone hydrochloride
pharmaceutical raw material
Dopamine hydrochloride
pharmaceutical raw material
Sodium calcium edetate
pharmaceutical raw material
The international HS code for Dihydroergotamine mesylate (CAS 6190-39-2) is 2939.69.
2939.69
2939 69 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
ADYPXRFPBQGGAH-UMYZUSPBSA-N
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O